ArticleMolecular medicine (Cambridge, Mass.)2022

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.

Ruo-Kai Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.